Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine
Phase 4
Completed
- Conditions
- Varicella
- Interventions
- Biological: varicella-1Biological: varicella-3Biological: varicella-5
- First Posted Date
- 2014-06-25
- Last Posted Date
- 2014-09-01
- Lead Sponsor
- Changchun Keygen Biological Products Co., Ltd.
- Target Recruit Count
- 716
- Registration Number
- NCT02173899
- Locations
- 🇨🇳
Shenzhen Luohu District Center for Disease Control and Prevention, Shenzhen, Guangdong, China
Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine
Phase 4
Completed
- Conditions
- Chickenpox
- Interventions
- Biological: Live Attenuated Varicella Vaccine
- First Posted Date
- 2013-03-25
- Last Posted Date
- 2013-10-16
- Lead Sponsor
- Changchun Keygen Biological Products Co., Ltd.
- Target Recruit Count
- 368
- Registration Number
- NCT01817270
- Locations
- 🇨🇳
Xinxing Center for Disease Control and Prevention, Yunfu, Guangdong, China
Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine
Phase 4
Completed
- Conditions
- Japanese EncephalitisChickenpox
- Interventions
- Biological: Live Attenuated Varicella Vaccine + Live Attenuated JE VaccineBiological: Live Attenuated Varicella VaccineBiological: live attenuated JE vaccine
- First Posted Date
- 2013-03-20
- Last Posted Date
- 2014-02-24
- Lead Sponsor
- Changchun Keygen Biological Products Co., Ltd.
- Target Recruit Count
- 497
- Registration Number
- NCT01815073
- Locations
- 🇨🇳
Guangzhou Haizhu District Center for Disease Control and Prevention, Guangzhou, Guangdong, China
© Copyright 2025. All Rights Reserved by MedPath